Have questions? Visit https://www.reddit.com/r/SNPedia

rs620861

From SNPedia

Orientationminus
Stabilizedminus
Make rs620861(C;C)
Make rs620861(C;T)
Make rs620861(T;T)
ReferenceGRCh38 38.1/141
Chromosome8
Position127323428
GeneCASC21, CASC8
is asnp
is mentioned by
dbSNPrs620861
dbSNP (classic)rs620861
ClinGenrs620861
ebirs620861
HLIrs620861
Exacrs620861
Gnomadrs620861
Varsomers620861
LitVarrs620861
Maprs620861
PheGenIrs620861
Biobankrs620861
1000 genomesrs620861
hgdprs620861
ensemblrs620861
geneviewrs620861
scholarrs620861
googlers620861
pharmgkbrs620861
gwascentralrs620861
openSNPrs620861
23andMers620861
SNPshotrs620861
SNPdbers620861
MSV3drs620861
GWAS Ctlgrs620861
GMAF0.3751
Max Magnitude0
? (C;C) (C;T) (T;T) 28


[PMID 19767752] Multiple loci on 8q24 associated with prostate cancer susceptibility


[PMID 19767755OA-icon.png] Identification of a new prostate cancer susceptibility locus on chromosome 8q24 (P = 1.3 x 10(-10), heterozygote OR = 1.17, 95% CI 1.10-1.24; homozygote OR = 1.33, 95% CI 1.21-1.45). See the entry for rs4242382, which states, "A joint-odds analysis indicates that rs4242382(A;A) individuals have increased prostate cancer odds of 3.15x or 1.77x if they are also carrying 2 or 1 rs620861(C) alleles, respectively."

OMIM611100
Desc
Variant
Relatedalso


[PMID 21814516OA-icon.png] A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression


[PMID 20690139] Meta-analysis of genome-wide and replication association studies on prostate cancer.


[PMID 21390317OA-icon.png] Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.


[PMID 24224612OA-icon.png] Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a hispanic population


[PMID 28399564OA-icon.png] Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.